tbuckley/cabot-search huggingface dataset:
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Authors: Mary B. Daly, Robert Pilarski, Michael Berry, Saundra S. Buys, Meagan Farmer, Susan Friedman, Judy E. Garber, Noah D. Kauff, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer K. Litton, Lisa Madlensky, Sofia D. Merajver, Kenneth Offit, Tuya Pal, Gwen Reiser, Kristen Mahoney Shannon, Elizabeth Swisher, Shaveta Vinayak, Nicoleta C. Voian, Jeffrey N. Weitzel, Myra J. Wick, Georgia L. Wiesner, Mary Dwyer, Susan Darlow
Journal: Journal of the National Comprehensive Cancer Network (2016)

The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.
Discriminative HMGA2 Isoform Expression in CD15+ Granulocytic Cells in Myeloid Metaplasia with Myelofibrosis (MMM).
Authors: Olivier Pierre-Louis, Joris Andrieux, Christophe Desterke, Eric Lippert, Vincent Praloran, Jean-Loup Demory, Marie-Caroline Le Bousse-Kerdiles, Chrystele Bilhou-Nabera
Journal: Blood (2004)
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAK BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTILY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM).
Authors: Marco Ladetto, Pos Sametti, Jw Donovan, M Astolfi, Luisa Giaccone, F Giaretta, F Vopata, S Bringhen, Antonio Palumbo, Benedetto Bruno, A Pileri, Jg Gribben, Mario Boccadoro
Journal: Blood (1996)
Phase II Trial of Combination of Bortezomib and Rituximab in Relapsed and/or Refractory Waldenstrom Macroglobulinemia: Preliminary Results.
Authors: Irene M. Ghobrial, Swaminathan Padmanabhan, Ashraf Badros, Marybeth Nelson, Renee Leduc, Xavier Leleu, Diane Warren, Jacob Soumerai, Ann Birner, Robert Schlossman, Nikhil Munshi, Paul Richardson, Steven P. Treon, Kenneth C. Anderson
Journal: Blood (2007)
MRI scans could help one in four men with suspected prostate cancer avoid biopsy
Authors: Susan Mayor
Journal: BMJ (2017)

Using multiparametric magnetic resonance imaging (MRI) in men with raised prostate specific antigen (PSA) levels could enable one in four to avoid having a biopsy and could reduce overdiagnosis of prostate cancer, a study validating this scanning technique against the most accurate reference test has shown.1

Men presenting with an elevated PSA level currently undergo transrectal ultrasound guided biopsy to check for prostate cancer. However, the PSA test is not always indicative of prostate cancer, so some of the 100 000 prostate biopsies in the UK each year are unnecessary. This biopsy …
The Outcome of Childhood Acute Lymphoblastic Leukemia with MLL Gene Rearrangement Treated with the Protocol (CCLG-ALL2008)
Authors: Yina SUN, Yi-huan Chai, Hai-long He, Jun LU, Yi WANG, Wen-li Zhao, Pei-fang Xiao, Jun-jie Fan, Shaoyan Hu
Journal: Blood (2014)
Detection of Five Common Fusion Oncogenes in Pakistani Children with Acute Lymphoblastic Leukemia and Their Association with Clinical Pattern and Treatment Outcome
Authors: Zafar Iqbal, Sabir Noreen, Aleem Aamer, Awan Tashfeen, Tahir Naeem, Asad Sultan, Ammara H Tahir, Muhammad Absar, Muhammad Azhar Chishti, Muhammad Faiyaz-ul-Haque, Ahmed Mukhtar Khalid, Muhammad Farooq Sabar, Mahmood Rasool, Agha Shabbir Ali, Amer Mahmood, Muhammad Akram, Tariq Saeed, Saleem Arsalan, Danish Mohsin, Ijaz Husssain Shah, Muhammad Khalid, Muhammad Asif, Mudassar Iqbal, Tanveer Akhtar
Journal: Blood (2012)
Is azathioprine an alternative for cyclophosphamide in the treatment of patients with proliferative lupus nephritis? Two-year results of the Dutch lupus nephritis study I
Authors: C Grootscholten, M Bijl, G Ligtenberg, EC Hagen, Awlvd Bake, JW de Glas-Vos, JC van Houwelingen, Rwhm Derksen, Jhm Berden
Journal: Annals of the Rheumatic Diseases (2004)
Molecular Heterogeneity as a Basis for Rational Therapeutics in Chronic Lymphocytic Leukemia.
Authors: Beatriz Herreros, Shaomeng Wang, James Robert Bischoff, Ruben Carro, Raul Córdoba, Julio Delgado, Jose Antonio García-Marco, Natalia Gómez, Juan F. García, José Francisco Tomáas, Joaquín Martínez-López, Antonia Rodríguez, Raquel Villuendas, Miguel A. Piris
Journal: Blood (2009)
The Tyrosine Kinase Inhibitor Dasatinib Enhances Glucocorticoid-Induced Apoptosis and Sensitizes Chronic Lymphocytic Leukemia Cells to Dexamethasone.
Authors: Michael W Harr, Paolo F. Caimi, Karen McColl, Fei Zhong, Shilen N Patel, Paul Barr, Clark W. Distelhorst
Journal: Blood (2009)
A painful swollen knee after a fall
Authors: Sheena Seewoonarain, Chris Servant
Journal: BMJ (2017)

Correspondence to: sseewoonarain@gmail.com

A 27 year old man stumbled down a step and twisted his left knee. He felt immediate severe pain in the knee and was unable to weight bear. On examination he had a swollen knee with a limited, painful range of movement. There was no obvious neurovascular deficit. Plain radiographs of the left knee were taken (fig …
Cord Blood-derived neurons by ectopic expression of SOX2 and c-MYC
Authors: Alessandra Giorgetti, Leopoldo Laricchia-Robbio, Raffaella Fazzina, Maria-Carolina Marchetto, Diana Yu, Mo Li, Yangling Mu, Antonio Adamo, Ida Paramonov, Julio Castaño-Cardoso, Montserrat Barragan, Fred Gage, Juan Carlos Izpisua
Journal: Blood (2011)
Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
Authors: Justus Nonhoff, Melanie Ricke-Hoch, Mirco Mueller, Britta Stapel, Tobias Pfeffer, Martina Kasten, Michaela Scherr, Constantin von Kaisenberg, Johann Bauersachs, Arash Haghikia, Denise Hilfiker-Kleiner
Journal: Cardiovascular Research (2016)

Peripartum cardiomyopathy (PPCM) is a systolic left ventricular dysfunction developing in the peripartum phase in previously healthy women. Relaxin-2 is a pregnancy hormone with potential beneficial effects in heart failure patients. We evaluated Relaxin-2 as a potential diagnostic marker and/or a therapeutic agent in PPCM.
The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
Authors: Valeria Governa, Emanuele Trella, Valentina Mele, Luigi Tornillo, Francesca Amicarella, Eleonora Cremonesi, Manuele Giuseppe Muraro, Hui Xu, Raoul Droeser, Silvio R. Däster, Martin Bolli, Raffaele Rosso, Daniel Oertli, Serenella Eppenberger-Castori, Luigi M. Terracciano, Giandomenica Iezzi, Giulio C. Spagnoli
Journal: Clinical Cancer Research (2017)

Abstract Purpose: Tumor infiltration by different T lymphocyte subsets is known to be associated with favorable prognosis in colorectal cancer. Still debated is the role of innate immune system. We investigated clinical relevance, phenotypes, and functional features of colorectal cancer–infiltrating CD66b+ neutrophils and their crosstalk with CD8+ T cells. Experimental Design: CD66b+ and CD8+ cell infiltration was analyzed by IHC on a tissue microarray including &amp;gt;650 evaluable colorectal cancer samples. Phenotypic profiles of tissue-infiltrating and peripheral blood CD66b+ cells were evaluated by flow cytometry. CD66b+/CD8+ cells crosstalk was investigated by in vitro experiments. Results: CD66b+ cell infiltration in colorectal cancer is significantly associated with increased survival. Interestingly, neutrophils frequently colocalize with CD8+ T cells in colorectal cancer. Functional studies indicate that although neutrophils are devoid of direct antitumor potential, coculture with peripheral blood or tumor-associated neutrophils (TAN) enhances CD8+ T-cell activation, proliferation, and cytokine release induced by suboptimal concentrations of anti-CD3 mAb. Moreover, under optimal activation conditions, CD8+ cell stimulation in the presence of CD66b+ cells results in increasing numbers of cells expressing CD45RO/CD62L “central memory” phenotype. Importantly, combined tumor infiltration by CD66b+ and CD8+ T lymphocytes is associated with significantly better prognosis, as compared with CD8+ T-cell infiltration alone. Conclusions: Neutrophils enhance the responsiveness of CD8+ T cells to T-cell receptor triggering. Accordingly, infiltration by neutrophils enhances the prognostic significance of colorectal cancer infiltration by CD8+ T cells, suggesting that they might effectively promote antitumor immunity. Clin Cancer Res; 23(14); 3847–58. ©2017 AACR.
Chidamide, a Novel Histone Deacetylase Inhibitor, Displays Potent Antitumor Activity Against MDS Cells Mainly through JAK2/STAT3 Signaling Inhibition
Authors: Chunkang Chang, Sida Zhao, Juan Guo, Youshan Zhao, Chengming Fei, Shucheng Gu, Xiao Li
Journal: Blood (2015)
Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).
Authors: Antonella Anastasia, Monica Balzarotti, Massimo Magagnoli, Michele Spina, Rita Mazza, L. Castagna, Andrea Nozza, Stefania Bramanti, Laura Giordano, Umberto Tirelli, Armando Santoro
Journal: Blood (2009)
Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Authors: Mitsune Tanimoto, Koichi Miyamura, Toshihiro Miyamoto, Kazuhito Yamamoto, Masafumi Taniwaki, Shinya Kimura, Kazuma Ohyashiki, Tatsuya Kawaguchi, Itaru Matsumura, Tomoko Hata, Hisashi Tsurumi, Shigeki Saito, Masayuki Hino, Seiji Tadokoro, Kuniaki Meguro, Hideo Hyodo, Masahide Yamamoto, Kohmei Kubo, Junichi Tsukada, Midori Kondo, Makoto Aoki, Hikaru Okada, Masamitsu Yanada
Journal: Blood (2014)
Bone Marrow Derived Mesenchymal Stem Cells from Splenic Marginal Zone Lymphoma Patients Exhibit Altered Proliferative Potential and B Lymphocyte Immunomodulatory Properties
Authors: Athanasia Kalyva, Charalampos Pontikoglou, Christina Kalpadakis, Athina Trakaki, Nikitas Zorzos, Maria Velegraki, Grigorios Panteloglou, Kallliopi Alpantaki, Gerasimos A. Pangalis, Helen A Papadaki
Journal: Blood (2015)
The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells
Authors: Stefanie AE Held, Annkristin Heine, Stefan Tenzer, Anita Bringmann, Hansjoerg Schild, Christoph Driessen, Peter Brossart
Journal: Blood (2011)
Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors
Authors: Shakti H. Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, Lori A. Ramkissoon, Noah F. Greenwald, Steven E. Schumacher, Ryan O’Rourke, Nathan Pinches, Patricia Ho, Hayley Malkin, Claire Sinai, Mariella Filbin, Ashley Plant, Wenya Linda Bi, Michael S. Chang, Edward Yang, Karen D. Wright, Peter E. Manley, Matthew Ducar, Sanda Alexandrescu, Hart Lidov, Ivana Delalle, Liliana C. Goumnerova, Alanna J. Church, Katherine A. Janeway, Marian H. Harris, Laura E. MacConaill, Rebecca D. Folkerth, Neal I. Lindeman, Charles D. Stiles, Mark W. Kieran, Azra H. Ligon, Sandro Santagata, Adrian M. Dubuc, Susan N. Chi, Rameen Beroukhim, Keith L. Ligon
Journal: Neuro-Oncology (2016)

Clinical genomics platforms are needed to identify targetable alterations, but implementation of these technologies and best practices in routine clinical pediatric oncology practice are not yet well established.Profile is an institution-wide prospective clinical research initiative that uses targeted sequencing to identify targetable alterations in tumors. OncoPanel, a multiplexed targeted exome-sequencing platform that includes 300 cancer-causing genes, was used to assess single nucleotide variants and rearrangements/indels. Alterations were annotated (Tiers 1-4) based on clinical significance, with Tier 1 alterations having well-established clinical utility. OncoCopy, a clinical genome-wide array comparative genomic hybridization (aCGH) assay, was also performed to evaluate copy number alterations and better define rearrangement breakpoints.Cancer genomes of 203 pediatric brain tumors were profiled across histological subtypes, including 117 samples analyzed by OncoPanel, 146 by OncoCopy, and 60 tumors subjected to both methodologies. OncoPanel revealed clinically relevant alterations in 56% of patients (44 cancer mutations and 20 rearrangements), including BRAF alterations that directed the use of targeted inhibitors. Rearrangements in MYB-QKI, MYBL1, BRAF, and FGFR1 were also detected. Furthermore, while copy number profiles differed across histologies, the combined use of OncoPanel and OncoCopy identified subgroup-specific alterations in 89% (17/19) of medulloblastomas.The combination of OncoPanel and OncoCopy multiplex genomic assays can identify critical diagnostic, prognostic, and treatment-relevant alterations and represents an effective precision medicine approach for clinical evaluation of pediatric brain tumors.
Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Yosuke Tanaka, Saiko Kurosawa, Kinuko Tajima, Yoshihiro Inamoto, Reiko Ito, Takashi Tanaka, Yoshitaka Inoue, Takayuki Ozawa, Akihisa Kawajiri, Akio Onishi, Keiji Okinaka, Shigeo Fuji, Sung-Won Kim, Ryuji Tanosaki, Takuya Yamashita, Takahiro Fukuda
Journal: Blood (2015)
Complete Molecular Remission (CMR 4.5) of CML Is Induced Faster by Dose – Optimized Imatinib and Predicts Better Survival - Results From the Randomized CML-Study IV
Authors: Rüdiger Hehlmann, Michael Lauseker, Benjamin Hanfstein, Martin C. Müller, Annette Schreiber, Ulrike Proetel, Markus Pfirrmann, Claudia Haferlach, Susanne Schnittger, Hermann Einsele, Jolanta Dengler, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Karsten Spiekermann, Gabriela M. Baerlocher, Gerhard Ehninger, Dominik Heim, Hermann Heimpel, Christoph Nerl, Stefan W. Krause, Dieter K. Hossfeld, Hans-Jochem Kolb, Andreas Hochhaus, Joerg Hasford, Susanne Saussele
Journal: Blood (2012)
What Van Halen Can Teach Us About the Care of Older Patients
Authors: Andrea Wershof Schwartz
Journal: JAMA Internal Medicine (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
The Role of Radiotherapy to Bulky Disease in the Rituximab Era: Results from Two Prospective Trials of the German High-Grade Non-Hodgkin- Lymphoma Study Group (DSHNHL) for Elderly Patients with DLBCL
Authors: Michael Pfreundschuh, Marita Ziepert, Marcel Reiser, Viola Poeschel, Sibylla Wilhelm, Tobias Gaska, Michael Heike, Norbert Schmitz, Christian Ruebe, Markus Loeffler, Joerg Schubert
Journal: Blood (2008)
Nilotinib in Chronic Myeloid Leukemia Patients in Chronic Phase (CMLCP) with Imatinib Resistance or Intolerance: 2-Year Follow-up Results of a Phase 2 Study.
Authors: Hagop M Kantarjian, Francis Giles, Kapil N. Bhalla, Richard A. Larson, Norbert Gattermann, Oliver G. Ottmann, Ariful Haque, Neil J. Gallagher, Michele Baccarani, Philipp D. le Coutre
Journal: Blood (2008)
The Influence of Uridine Diphosphate Glucuronosyl Transferase 1A Promoter Polymorphism, βS-Globin Gene Haplotype, Co-Inherited α-Thalassemia Trait and Hb F on Steady-State Serum Bilirubin Levels in Sickle Cell Anemia.
Authors: Adekunle D. Adekile, Ferdane Kutlar, Kathleen McKie, Anthony Addington, Dedrey Elam, Betsy Clair, Leslie Holley, Abdullah Kutlar
Journal: Blood (2004)
Cafestol, the cholesterol-raising factor in boiled coffee, increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis
Authors: S.M. Post, B. de Roos, M. Vermeulen, L. Afman, M.C. Jong, V.E. Dahlmans, L.M. Havekes, F. Stellaard, M.B. Katan, H.M. Princen
Journal: Hepatology (1999)
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Journal: Annals of Internal Medicine (2009)

Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population.The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals.The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus
Authors: Xuan Liu, Emily Speranza, César Muñoz-Fontela, Sam Haldenby, Natasha Y. Rickett, Isabel Garcia-Dorival, Yongxiang Fang, Yper Hall, Elsa-Gayle Zekeng, Anja Lüdtke, Dong Xia, Romy Kerber, Ralf Krumkamp, Sophie Duraffour, Daouda Sissoko, John Kenny, Nichola Rockliffe, E. Diane Williamson, Thomas R. Laws, Magassouba N’Faly, David A. Matthews, Stephan Günther, Andrew R. Cossins, Armand Sprecher, John H. Connor, Miles W. Carroll, Julian A. Hiscox
Journal: Genome biology (2017)

In 2014, Western Africa experienced an unanticipated explosion of Ebola virus infections. What distinguishes fatal from non-fatal outcomes remains largely unknown, yet is key to optimising personalised treatment strategies. We used transcriptome data for peripheral blood taken from infected and convalescent recovering patients to identify early stage host factors that are associated with acute illness and those that differentiate patient survival from fatality.The data demonstrate that individuals who succumbed to the disease show stronger upregulation of interferon signalling and acute phase responses compared to survivors during the acute phase of infection. Particularly notable is the strong upregulation of albumin and fibrinogen genes, which suggest significant liver pathology. Cell subtype prediction using messenger RNA expression patterns indicated that NK-cell populations increase in patients who survive infection. By selecting genes whose expression properties discriminated between fatal cases and survivors, we identify a small panel of responding genes that act as strong predictors of patient outcome, independent of viral load.Transcriptomic analysis of the host response to pathogen infection using blood samples taken during an outbreak situation can provide multiple levels of information on both disease state and mechanisms of pathogenesis. Host biomarkers were identified that provide high predictive value under conditions where other predictors, such as viral load, are poor prognostic indicators. The data suggested that rapid analysis of the host response to infection in an outbreak situation can provide valuable information to guide an understanding of disease outcome and mechanisms of disease.
Serotoninergic Mechanisms Play a Major Role on Platelet-Mediated Thrombogenicity: Studies under Flow Conditions and Effects of Inhibitory Strategies.
Authors: Ana M. Galan, Irene Lopez-Vilches, Maribel Diaz-ricart, Fulgencio Navalon, Marcos Pino, Esther Gomez, Cristobal Gasto, Gines Escolar
Journal: Blood (2005)
MLLT10 Gene Promiscuity Unravels Involvement of RNA Processing Genes in Pediatric T-Acute Lymphoblastic Leukemia
Authors: Lucia Brandimarte, Valentina Pierini, Danika Di Giacomo, Paolo Gorello, Caterina Matteucci, Marco Giordan, Giovanni Cazzaniga, Geertruy te Kronnie, Roberta La Starza, Cristina Mecucci
Journal: Blood (2012)
Hereditary Thrombocythemia: Clinical Characteristics, Biological Markers and Long-Term Follow-up in 4 Families Observed in a Single Hematologic Pediatric Center
Authors: Fiorina Giona, Angela Amendola, Luciana Teofili, Giovanna Palumbo, Francesca Mancini, Vittorio Nunes, Massimiliano Rea, Maurizio Martini, Robert Foa
Journal: Blood (2008)
Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone
Authors: Areej El-Jawahri, Sean F. Heavey, Thomas W. LeBlanc, Harry Vandusen, Gregory Abel, David P. Steensma, Lara Traeger, Amir T. Fathi, Daniel J. DeAngelo, Martha Wadleigh, Gabriela Hobbs, Philip C. Amrein, Richard M. Stone, Karen K. Ballen, Yi-Bin Chen, Jennifer S. Temel
Journal: Blood (2015)
Rapamycin Has Biological Activity in a Subset of Patients with Myelodysplastic Syndrome - Results of a Phase I/II Trial.
Authors: Uwe Platzbecker, Michael Haase, Regina Herbst, Anette Hanel, Karsten Voigtmann, Christian Thiede, Brigitte Mohr, Eberhard Schleyer, Traugott Leopold, Mathias Hanel, Gerhard Ehninger, Martin Bornhauser
Journal: Blood (2004)